Medifast (MED) Accumulated Expenses (2014 - 2020)

Medifast has reported Accumulated Expenses for 7 years, with the latest figure at $325000.0 in Q4 2020.

• For the quarter ending Q4 2020, Accumulated Expenses fell 94.19% year-over-year to $325000.0; the trailing twelve-month figure through Dec 2020 stood at $325000.0 (down 94.19% YoY), and the FY2020 full-year result was $325000.0, down 94.19% from the prior year.
• Accumulated Expenses for Q4 2020 stood at $325000.0, down from $5.6 million in the prior quarter.
• The five-year high for Accumulated Expenses was $6.6 million in Q4 2017, with the low at $121000.0 in Q4 2016.
• Historically, Accumulated Expenses has averaged $3.1 million across 5 years, with a median of $2.9 million in 2018.
• Annual changes were most pronounced in 2017 — Accumulated Expenses soared 5341.32% — and 2020, when it sank 94.19%.
• Medifast's Accumulated Expenses stood at $121000.0 in 2016, then soared by 5341.32% to $6.6 million in 2017, then fell by 15.77% to $5.5 million in 2018, then grew by 0.94% to $5.6 million in 2019, then slumped by 94.19% to $325000.0 in 2020.
• The last three Accumulated Expenses figures came in at $325000.0 (Q4 2020), $5.6 million (Q4 2019), and $5.5 million (Q4 2018), per Business Quant data.